about
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidencesMPINet: metabolite pathway identification via coupling of global metabolite network structure and metabolomic profile.Anti-cancer activities of ω-6 polyunsaturated fatty acidsIntegration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer.Pomegranate and its components as alternative treatment for prostate cancer.Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence.Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular MechanismsDiscovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling.Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2.Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway.Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells.Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer.In Vitro Pro-apoptotic and Anti-migratory Effects of Ficus deltoidea L. Plant Extracts on the Human Prostate Cancer Cell Lines PC3.Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression.The implications of signaling lipids in cancer metastasis
P2860
Q30234898-B880E8D9-BFA8-437F-9F7D-08ABCB3CE187Q33892898-F6FDE7F4-89AE-4D3B-81C9-ED9B187CE56FQ34424444-2BA1BE3C-5904-4E21-BF8D-CC4FF73DCA62Q36569962-54017D11-6C10-4ADF-9DED-CDDA9E0BE5FDQ38243393-4099F224-517E-4CE7-B010-8090E2354488Q38838580-C809BD96-4967-4FE6-9DCA-B91EF4B8A793Q38854428-BFCFA383-1389-43CF-AD04-A9A46B67E843Q41458701-4D2D8110-AC07-497C-87CD-AECCB879E832Q42123446-BBC24F3D-2E33-491F-A822-43EA97D7195EQ47102609-DB9BAE49-F221-4F41-BE31-F92DF9E2E9FFQ47224220-4EC7E2F3-762F-4305-A173-69AA4CDEFB8AQ47679295-2D2C31C7-B4CD-4544-82C3-E65603EC1C13Q48503176-B9F12FBA-5207-4100-90A7-22E885F6D01DQ55097447-D0F46093-76AB-400A-9BD7-38DCEC8C4ACBQ58705856-09EC285B-D76D-4128-BE99-08D934B8CBF9
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Arachidonic acid metabolism in human prostate cancer
@ast
Arachidonic acid metabolism in human prostate cancer
@en
Arachidonic acid metabolism in human prostate cancer
@nl
type
label
Arachidonic acid metabolism in human prostate cancer
@ast
Arachidonic acid metabolism in human prostate cancer
@en
Arachidonic acid metabolism in human prostate cancer
@nl
prefLabel
Arachidonic acid metabolism in human prostate cancer
@ast
Arachidonic acid metabolism in human prostate cancer
@en
Arachidonic acid metabolism in human prostate cancer
@nl
P2093
P2860
P356
P1476
Arachidonic acid metabolism in human prostate cancer
@en
P2093
Carrie A Cartwright
Ina N Prokhorova
Nora M Navone
Patricia Troncoso
Peiying Yang
Robert A Newman
P2860
P304
P356
10.3892/IJO.2012.1588
P407
P50
P577
2012-08-10T00:00:00Z